About Us

Why Our Company

image78

Enzolytics, Inc. is a drug development company committed to the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases.  Enzolytics is committed to creating drugs for the better health of mankind. 

How We Help

image79

Enzolytics, Inc.'s  flagship compound ITV-1 is a suspension of Inactivated Pepsin Fragment (IPF), which studies have shown is effective in the treatment of HIV. IPF is the active drug substance of ITV-1 and is a purified extract of porcine pepsin. ITV-1 has been shown to modulate the immune system. IPF is a platform technology that can be used to facilitate a broad range of applications. It is free from major neurological, gastrointestinal and hematological side effects seen in the anti-retrovirals in use today. IPF has not shown to be subject to viral resistance and is cost effective.

Experience the Difference

image80

This bio-product has shown low toxicity and is well accepted by the body system. Clinical trials in Bulgaria show improvements in immunity. 

Team

image81

Harry Zhabilov

President and CEO

Contact Us

Drop us a line!

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Enzolytics, Inc.

120 West Pomona Avenue, Monrovia, California 91016, United States

(626)-538-4779